Synthesis of potential HIV integrase inhibitors inspired by natural polyphenol structures

References

• Artico M, Di Santo R, Costi R, Novellino E, Greco G, Massa S, Tramontano S, Marongiu ME, De Montis A, La Colla P. 1998. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 Integrase: synthesis, biological evaluation, and molecular modeling. J Med Chem. 41:3948–3960.10.1021/jm9707232
   PubMed Web of Science ®Google Scholar
• Charvat TT, Lee DJ, Robinson WE, Chamberlin AR. 2006. Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase. Bioorg Med Chem. 14:4552–4567.10.1016/j.bmc.2006.02.030
   PubMed Web of Science ®Google Scholar
• Chatgilialoglu C. 1988. Tris(trimethylsilyl)silane. A new reducing agent. J Org Chem. 53:3641–3642.10.1021/jo00250a051
   Web of Science ®Google Scholar
• Chiu TK, Davies DR (2004). Structure and function of HIV-1 integrase. Curr Top MedChem. 4: 965–977.10.2174/1568026043388547
   PubMed Web of Science ®Google Scholar
• Corona A, di Leva FS, Rigogliuso G, Pescatori L, Madia VN, Subra F, Delelis O, Esposito F, Cadeddu M, Costi R, et al. 2016. New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H. Antiviral Res. 134:236–243.10.1016/j.antiviral.2016.09.008
   PubMed Web of Science ®Google Scholar
• Cuzzucoli Crucitti G, Métifiot M, Pescatori L, Messore A, Madia VN, Pupo G, Saccoliti F, Scipione L, Tortorella S, Esposito F, et al. 2015. Structure–activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain. J Med Chem. 58:1915–1928.10.1021/jm501799 k
   PubMed Web of Science ®Google Scholar
• Dhimitruka I, SantaLucia J, Jr. 2006. Investigation of the Yamaguchi esterification mechanism. Synthesis of a Lux-S enzyme inhibitor using an improved esterification method. Org Lett. 8:47–50.10.1021/ol0524048
   PubMed Web of Science ®Google Scholar
• Esposito D, Craigie RFE, Carter GT. 1999. HIV integrase structure and function. Adv Virus Res. 52:319–333.10.1016/S0065-3527(08)60304-8
   PubMed Web of Science ®Google Scholar
• Fesen MR, Kohn KW, Leteurtre F, Pommier Y. 1993. Inhibitors of human immunodeficiency virus integrase. Proc Natl Acad Sci USA. 90:2399–2403.10.1073/pnas.90.6.2399
   PubMed Web of Science ®Google Scholar
• Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Yung J, Kohn KW. 1994. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem Pharmacol. 48:595–608.10.1016/0006-2952(94)90291-7
   PubMed Web of Science ®Google Scholar
• Inanaga J, Hirata K, Saeki H, Katsuki T, Yamaguchi M. 1979. A rapid esterification by means of mixed anhydride and its application to large-ring lactonization. Bull Chem Soc Jpn. 52:1989–1993.10.1246/bcsj.52.1989
   Web of Science ®Google Scholar
• Ingale KB, Bhatia MS. 2011. HIV-1 integrase inhibitors: a review of their chemical development. Antivir Chem Chemother. 22:95–105.10.3851/IMP1740
   PubMedGoogle Scholar
• Kamiński ZJ, Paneth P, Rudziński J. 1998. A study on the activation of carboxylic acids by means of 2-chloro-4,6-dimethoxy-1,3,5-triazine and 2-chloro-4,6-diphenoxy-1,3,5-triazine. J Org Chem. 63:4248–4255.10.1021/jo972020y
   Web of Science ®Google Scholar
• Kang Y, Mei Y, Du Y, Jin Z. 2003. Total synthesis of the highly potent anti-HIV natural product daurichromenic acid along with its two chromane derivatives, rhododaurichromanic acids A and B. Org Lett. 5:4481–4484.10.1021/ol030109 m
   PubMed Web of Science ®Google Scholar
• Koehn FE, Carter GT. 2005. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 4:206–220.10.1038/nrd1657
   PubMed Web of Science ®Google Scholar
• König CM, Harms K, Koert U. 2007. Stereoselective synthesis of methyl 7-dihydro-trioxacarcinoside B. Org Lett. 9:4777–4779.10.1021/ol702078t
   PubMed Web of Science ®Google Scholar
• Lin Z, Neamati N, Zhao H, Kiryu Y, Turpin JA, Aberham C, Strebel K, Kohn K, Witvrouw M, Pannecouque C, et al. 1999. Chicoric acid analogues as HIV-1 integrase inhibitors. J Med Chem. 42:1401–1414.10.1021/jm980531 m
   PubMed Web of Science ®Google Scholar
• Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y. 1995. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol. 49:1165–1170.10.1016/0006-2952(95)98514-A
   PubMed Web of Science ®Google Scholar
• Mazumder A, Wang S, Neamati N, Nicklaus M, Sunder S, Chen J, Milne GWA, Rice WG, Burke TR, Jr, Pommier Y. 1996. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. J Med Chem. 39:2472–2481.10.1021/jm960074e
   PubMed Web of Science ®Google Scholar
• Mazumder A, Neamati N, Sunder S, Schulz J, Pertz H, Eich E, Pommier Y. 1997. Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. J Med Chem. 40:3057–3063.10.1021/jm970190x
   PubMed Web of Science ®Google Scholar
• Nair V, Okello M. 2015. Integrase inhibitor prodrugs: approaches to enhancing the anti-HIV activity of β-diketo acids. Molecules. 20:12623–12651.10.3390/molecules200712623
   PubMed Web of Science ®Google Scholar
• Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Nicklaus MC, Milne GWA, Proksa B, Pommier Y. 1997. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. J Med Chem. 40:942–951.10.1021/jm960759e
   PubMed Web of Science ®Google Scholar
• Righi G, Pescatore G, Bonadies B, Bonini C. 2001. A study on the chelation control in the regioselective opening of 2,3-bifunctionalized epoxides. Tetrahedron. 57:5649–5656.10.1016/S0040-4020(01)00492-6
   Web of Science ®Google Scholar
• Sarmini K, Kenndler E. 1999. Ionization constants of weak acids and bases in organic solvents. J Biochem Biophys Methods. 38:123–137.10.1016/S0165-022X(98)00033-5
   PubMed Web of Science ®Google Scholar
• Shibuya H, Kawashima K, Narita N, Ikeda M, Kitagawa I. 1992. Sphingolipids and glycerolipids. Part II. Syntheses of 2 pairs of enantiomeric C18-sphingosines and a palmitoyl analog of gaucher spleen glucocerebroside. Chem Pharm Bull. 40:1154–1165.10.1248/cpb.40.1154
   Web of Science ®Google Scholar
• Summa V, Petrocchi A, Bonelli F, Crescenzi B, Donghi M, Ferrara M, Fiore F, Gardelli C, Gonzalez Paz OG, Hazuda DJ, et al. 2008. Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. J Med Chem. 51:5843–5855.10.1021/jm800245z
   PubMed Web of Science ®Google Scholar
• Trost BM, Chisholm JD, Wrobleski ST, Jung M. 2002. Ruthenium-catalyzed alkene-alkyne coupling: synthesis of the proposed structure of amphidinolide A. J Am Chem Soc. 124:12420–12421.10.1021/ja027883+
   PubMed Web of Science ®Google Scholar
• Wolf E, Spenser ID. 1995. [2,3-13C2]-4-Hydroxy-L-threonine. J Org Chem. 60:6937–6940.10.1021/jo00126a052
   Web of Science ®Google Scholar
• Yoshida M, Nakatani K, Shishido K. 2009. Total synthesis of radulanin H and proposed structure of radulanin E. Tetrahedron. 65:5702–5708.10.1016/j.tet.2009.05.027
   Web of Science ®Google Scholar
• Yoshimura Y, Yamazaki Y, Kawahata M, Yamaguchi K, Takahata H. 2007. Design and synthesis of a novel ring-expanded 4′-thio-apio-nucleoside derivatives. Tetrahedron Lett. 48:4519–4522.10.1016/j.tetlet.2007.04.139
   Web of Science ®Google Scholar
• Zhan P, Pannecouque C, De Clercq E, Liu X. 2016. Anti-HIV drug discovery and development: current innovations and future trends. J Med Chem. 59:2849–2878.10.1021/acs.jmedchem.5b00497
   PubMed Web of Science ®Google Scholar
• Zhao H, Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Milne GWA, Pommier Y, Burke TR Jr. 1997. Coumarin-based inhibitors of HIV Integrase. J Med Chem. 40:242–249.10.1021/jm960450v
   PubMed Web of Science ®Google Scholar